Suzhou, China

Jing Deng

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Jing Deng: Innovator in Pharmaceutical Compositions

Introduction

Jing Deng is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cancer treatments. With a total of 2 patents, his work focuses on innovative compositions that aim to improve patient outcomes in oncology.

Latest Patents

Jing Deng's latest patents include a pharmaceutical composition of MDM2 inhibitor and its use for preventing and/or treating diseases, particularly cancer. This patent outlines compositions that combine an MDM2 inhibitor with one or more anti-cancer agents. The methods described involve administering these compositions to patients in need, showcasing a novel approach to cancer treatment.

Another significant patent is the combination of BCL-2/BCL-XL inhibitors with chemotherapeutic agents. This disclosure provides a pharmaceutical composition that includes a Bcl-2/Bcl-xL inhibitor, a chemotherapeutic agent, and a pharmaceutically acceptable carrier. The methods for treating cancer described in this patent emphasize the enhanced anti-tumor effects achieved through this combination, offering promising avenues for future cancer therapies.

Career Highlights

Jing Deng has worked with Ascentage Pharma, a company known for its focus on innovative cancer therapies. His role in this organization has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Jing has collaborated with notable professionals in the field, including Dajun Yang and Yifan Zhai. These collaborations have further enriched his research and development efforts, leading to advancements in cancer treatment methodologies.

Conclusion

Jing Deng's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight his role as a significant inventor in the field. His patents reflect a commitment to improving therapeutic options for patients, showcasing the potential of innovative pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…